B. Braun Executive and Leadership Team

David Wilbow, the Chief Financial Officer at B. Braun, directs the global financial strategy and capital allocation for the organization. Wilbow oversees the management of fiscal reporting, ensuring transparency and accuracy across all international business units. By analyzing market volatility and economic indicators, the Chief Financial Officer provides the executive team with actionable insights to guide investment decisions in medical device manufacturing. This leadership role involves optimizing the company's balance sheet to support ongoing research and development in pharmaceutical solutions. David Wilbow drives cost-efficiency initiatives that streamline internal processes without compromising the quality of medical products. Through rigorous financial planning and risk assessment, the Chief Financial Officer secures the capital necessary for long-term infrastructure projects. Wilbow maintains a focus on maximizing shareholder value while ensuring that the company remains well-positioned to navigate the complexities of the global healthcare market.

Yazmin Ruiz, the Chief Financial Officer (Mexico) at B. Braun, manages the financial operations and fiscal compliance for the Mexican market. Ruiz oversees the budgeting process for regional manufacturing facilities, ensuring that resources are allocated effectively to support production targets. By monitoring local economic conditions, the Chief Financial Officer (Mexico) identifies potential financial risks and implements mitigation strategies to protect the company's regional assets. This leadership role involves coordinating with local tax authorities and regulatory bodies to ensure full adherence to legal requirements. Yazmin Ruiz drives the implementation of automated financial reporting systems that improve data accuracy and operational speed. Through the analysis of regional sales performance, the Chief Financial Officer (Mexico) provides strategic guidance to the local management team. Ruiz prioritizes the maintenance of a robust financial foundation, enabling the company to sustain its growth and service delivery within the competitive Mexican healthcare sector.

Scott Farrell, the Group Chief Financial Officer at B. Braun, architects the overarching financial architecture for the entire multinational enterprise. Farrell oversees the consolidation of global financial data, providing the Board with a comprehensive view of the company's fiscal health. By directing the long-term financial planning and capital structure, the Group Chief Financial Officer ensures that the organization maintains the liquidity required for strategic acquisitions and innovation. This leadership role involves managing investor relations and communicating the company's financial performance to external stakeholders. Scott Farrell drives the adoption of advanced financial analytics tools that enhance forecasting accuracy and strategic decision-making. Through the oversight of global treasury functions, the Group Chief Financial Officer mitigates currency risks and optimizes cash flow across all operating regions. Farrell maintains a focus on sustainable financial growth, ensuring that the company's fiscal policies align with its mission to deliver high-quality medical solutions worldwide.

Muhammad Arqam, the Chief Financial Officer & Head of Strategic Accounts Management at B. Braun, integrates financial oversight with the management of high-value client relationships. Arqam directs the financial modeling for large-scale hospital contracts, ensuring that service agreements remain profitable and sustainable. By analyzing the financial impact of strategic accounts, the Chief Financial Officer & Head of Strategic Accounts Management identifies opportunities for revenue expansion through bundled service offerings. This leadership role involves negotiating complex terms with major healthcare providers to secure long-term partnerships. Muhammad Arqam drives the alignment of account management strategies with the company's broader financial goals. Through the continuous monitoring of account performance, the Chief Financial Officer & Head of Strategic Accounts Management ensures that client needs are met while maintaining strict adherence to budgetary constraints. Arqam prioritizes the development of value-based pricing models that reflect the high quality of the company's medical products and services.

Punrada Lertkomonsuk, the Chief Financial Officer, B Braun Ltd (Thailand) at B. Braun, manages the financial health and regulatory compliance for the Thai subsidiary. Lertkomonsuk oversees the local accounting functions, ensuring that all financial reporting meets both local standards and corporate requirements. By analyzing regional market trends, the Chief Financial Officer, B Braun Ltd (Thailand) provides the local leadership team with insights to optimize resource allocation for medical product distribution. This leadership role involves managing local banking relationships and ensuring the availability of capital for regional operations. Punrada Lertkomonsuk drives the implementation of cost-saving measures that improve the profitability of the Thai business unit. Through the oversight of local tax and audit processes, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that the company maintains a strong reputation for integrity and financial stability. Lertkomonsuk prioritizes the alignment of local financial strategies with the company's global mission to improve patient care.

Leigh Stradford, the Senior VP & Chief Human Resources Officer at B. Braun, directs the global talent strategy and organizational development initiatives. Stradford oversees the recruitment, retention, and professional development of the workforce, ensuring that the company attracts top-tier talent in the medical device and pharmaceutical sectors. By implementing comprehensive training programs, the Senior VP & Chief Human Resources Officer fosters a culture of innovation and clinical excellence. This leadership role involves managing employee relations and ensuring that corporate policies support a diverse and inclusive work environment. Leigh Stradford drives the alignment of human capital strategies with the company's operational goals, ensuring that teams are equipped to meet the demands of a global market. Through the development of performance management systems, the Senior VP & Chief Human Resources Officer supports the growth of individual employees and the organization as a whole. Stradford prioritizes the well-being of the workforce, recognizing that human talent remains the primary driver of the company's success.

Michael Dickscheid, the Managing Director at B. Braun, directs the overarching operational strategy for the medical device manufacturing division. Dickscheid oversees the integration of advanced infusion therapy technologies into clinical workflows across European markets. By coordinating with internal research teams, the Managing Director ensures that product development cycles align with evolving hospital pharmacy requirements. This leadership role involves optimizing supply chain efficiency to maintain high availability of critical surgical instruments. Michael Dickscheid drives the implementation of quality control protocols that meet stringent international medical standards. Through rigorous oversight of manufacturing output, the Managing Director secures the company's market position as a leader in pharmaceutical solutions. Dickscheid maintains focus on scaling production capabilities to meet the rising demand for specialized wound care products, ultimately supporting the broader corporate mission of enhancing patient safety and clinical efficacy throughout the global healthcare landscape.

Geoff Brown, the Managing Director at B. Braun, architects the strategic expansion of dialysis services within the North American healthcare sector. Brown manages the deployment of specialized medical equipment to clinical facilities, ensuring seamless integration with existing hospital infrastructure. By analyzing regional market trends, the Managing Director identifies opportunities for service diversification in the renal care space. This leadership role involves fostering partnerships with healthcare providers to improve patient access to life-saving dialysis treatments. Geoff Brown drives operational excellence by streamlining service delivery models and reducing administrative overhead for partner clinics. Through consistent monitoring of clinical performance metrics, the Managing Director ensures that all operations adhere to the highest safety standards. Brown prioritizes the development of sustainable service frameworks that support long-term growth, effectively positioning the company as a primary provider of comprehensive renal care solutions across the continent.

Sinan Esermann, the Managing Director at B. Braun, oversees the strategic development of surgical instrument portfolios across emerging markets. Esermann directs the implementation of localized marketing initiatives that highlight the precision and reliability of the company's surgical tools. By collaborating with regional medical boards, the Managing Director ensures that product offerings meet specific clinical needs in diverse healthcare environments. This leadership role involves managing complex distribution networks to guarantee the timely delivery of critical medical supplies. Sinan Esermann drives the adoption of innovative wound care technologies by providing comprehensive training programs for clinical staff. Through the optimization of regional sales channels, the Managing Director strengthens the company's footprint in high-growth territories. Esermann maintains a focus on operational agility, allowing the organization to respond rapidly to shifting regulatory requirements and market demands, thereby securing a competitive advantage in the global medical device industry.

Fahad Faheem, the Managing Director at B. Braun, leads the strategic integration of hospital pharmacy solutions across the Middle East and Asia. Faheem oversees the deployment of automated medication management systems designed to enhance patient safety and reduce clinical errors. By aligning product capabilities with local healthcare regulations, the Managing Director ensures compliance and operational efficiency in complex hospital environments. This leadership role involves managing cross-functional teams to deliver end-to-end infusion therapy solutions. Fahad Faheem drives the expansion of the company's service portfolio by identifying gaps in current hospital infrastructure and providing targeted technological interventions. Through the cultivation of strong relationships with key healthcare stakeholders, the Managing Director secures long-term partnerships that support sustainable revenue growth. Faheem prioritizes the delivery of high-quality medical products, ensuring that the company remains a trusted partner for healthcare institutions seeking to modernize their pharmacy operations.